Design Therapeutics, Inc. · NASDAQ:DSGN

Point72 Asset Management, L.P. reported a 5.20% stake in Design Therapeutics, Inc. (Schedule 13G)

Event Aug 27, 2025 · Filed Aug 28, 2025

Point72 Asset Management, L.P. reported a 5.20% stake in Design Therapeutics, Inc., 2,942,719 shares, as a passive investor on Aug 27, 2025. Filed Aug 28, 2025 (Schedule 13G).

Stake
5.20%
Shares
2,942,719
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.5.20%2,942,719
Point72 Capital Advisors, Inc.5.20%2,942,719
Steven A. Cohen5.20%2,942,719

Source

View original at SEC

Related